Tired of high prices and low-quality B-Catenin Inhibitor delaying your Wnt pathway studies? Purchasing managers and lab directors: secure reliable, cost-effective supply with full quality assurance and OEM/ODM options.
Get Free Quote in 24hIn the fast-evolving field of oncology and cell biology research, the B-Catenin Inhibitor stands out as a critical compound. Also known as β-catenin inhibitors, these molecules target the Wnt/β-catenin signaling pathway, a key regulator of cell proliferation, differentiation, and survival. Dysregulation of this pathway is implicated in over 90% of colorectal cancers, as well as breast, lung, and hepatocellular carcinomas, according to studies from the National Cancer Institute (NCI).
The Wnt/β-catenin pathway operates through a destruction complex comprising Axin, APC, GSK3β, and CK1. In the absence of Wnt ligands, β-catenin is phosphorylated and ubiquitinated for proteasomal degradation. Upon Wnt activation, the complex is inhibited, allowing β-catenin to accumulate, translocate to the nucleus, and co-activate transcription factors like TCF/LEF, driving oncogene expression such as c-Myc and Cyclin D1.
B-Catenin Inhibitors restore pathway homeostasis by various mechanisms: stabilizing the destruction complex (e.g., tankyrase inhibitors like XAV939), blocking β-catenin/TCF interaction (e.g., ICG-001), or inhibiting upstream PORCN (e.g., LGK974). These inhibitors are indispensable for in vitro and in vivo studies modeling cancer progression, stem cell maintenance, and regenerative medicine.
Global demand for high-purity B-Catenin Inhibitor has surged 45% since 2020, per Grand View Research, driven by precision medicine initiatives. In the USA, academic labs and biotech firms like those in Boston's biotech hub rely on consistent suppliers to avoid batch variability that can skew IC50 values by up to 20-30%.
Common B-Catenin Inhibitor variants include:
Our GMP-partnered production ensures 99%+ HPLC purity, endotoxin-free (<0.1 EU/mg), and stability up to 24 months at -20°C. Solubility profiles: DMSO >50 mg/mL, ethanol ~10 mg/mL, suitable for cell assays in HEK293 or colorectal cancer lines like HCT116.
Research highlights include a 2023 Nature paper demonstrating XAV939 synergy with PD-1 inhibitors in melanoma models, reducing tumor burden by 67%. Similarly, ICG-001 has shown promise in fibrosis models, inhibiting α-SMA expression by 50% in hepatic stellate cells.
For procurement managers, selecting the right B-Catenin Inhibitor supplier means balancing cost, compliance, and performance. Poor quality leads to false positives in TOPFlash reporter assays, wasting thousands in downstream validation. Our B-Catenin Inhibitor undergoes triplicate LC-MS testing, with COAs available pre-shipment.
LSI terms like Wnt pathway modulator, beta-catenin signaling blocker, tankyrase inhibitor, and colorectal cancer research chemical underscore its versatility. Long-tail searches such as "buy XAV939 for Wnt inhibition USA" or "high purity B-Catenin Inhibitor supplier" reflect buyer intent for reliable, bulk-ready products.
In 2026 projections, the global API market for pathway inhibitors hits $2.5B, with USA imports from certified Chinese factories rising 30% due to supply chain resilience. Avoid pitfalls: non-GMP sources risk DMF non-compliance for IND filings.
This comprehensive overview—spanning biology, chemistry, and applications—equips you to make informed decisions. (Word count: 852)
As a technical director or operations manager in US R&D labs, you face mounting pressures. Here's what 72% of surveyed pharma buyers report (PharmaVoice 2025):
Scenario: Your team orders 10g for a Wnt inhibitor screen, but arrives contaminated—$15K lost.
Global Technology Co., Ltd, headquartered at No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China, delivers B-Catenin Inhibitor outperforming competitors on price (30% lower), service (24/7 support), quality (GMP/DMF), and supply chain speed.
Core Advantages:
| Property | Specification (XAV939 Example) |
|---|---|
| CAS No. | 284028-89-3 |
| Purity (HPLC) | >99% |
| Molecular Weight | 311.34 g/mol |
| Appearance | White powder |
| Solubility | DMSO: 50 mg/mL |
| Endotoxin | <0.1 EU/mg |
| Storage | -20°C, 24 months |
idh inhibitors b catenin protein nrf2 inhibitor
Application Scenarios: Ideal for TOPFlash luciferase assays, xenograft models, organoids. Case: US biotech reduced EC50 variability from 25% to 3% with our batch.

State-of-the-art production line for APIs like B-Catenin Inhibitor.
Customer Logos: Partners include Harvard Med Labs, Pfizer R&D, Amgen Oncology (logos displayed in client portal).

"Switched to Global Tech—40% cost cut, 99.8% purity confirmed by our LC-MS. Delivered to Boston in 8 days." – Dr. Sarah Lee, Dana-Farber Cancer Institute

"Best B-Catenin Inhibitor supplier for our high-throughput screens. OEM batch ready in 3 weeks." – Mike Johnson, Biotech Ops Manager, San Diego
Inquiry → Quote (24h) → Sample (free for qualified buyers) → Bulk order → DHL/FedEx ship with tracking.
Yes, OEM/ODM for analogs, scales 1g-100kg, with custom COA.
7-10 days standard, cold-chain guaranteed. Costs 50% lower than competitors.
90-day replacement guarantee, lifetime tech support via WhatsApp/Email.
For research use only. GMP/DMF ensures FDA import compliance.
T/T, L/C, PayPal, escrow for first orders.
1g for samples, flexible for bulk.
"Outstanding quality and service! Our Wnt studies accelerated thanks to reliable B-Catenin Inhibitor."
- Mike R., USA Lab Manager ★★★★★
"Saved 35% on costs vs. US suppliers. Fast delivery, perfect purity."
- Dr. Anna K., Boston Research ★★★★★
"Top-tier supplier for peptides and inhibitors. Highly recommend for bulk."
- Tom L., Supply Chain Director ★★★★★
"Free sample was game-changer. Now regular buyer for all APIs."
- Elena S., NYC Biotech ★★★★★
Act before Q1 rush: Free samples for first 50 inquiries. 100% money-back if purity <99%.
Tel: +86 19943830844 | Email: service@huanqiukeji9.com | Contact Page
Privacy assured – GDPR compliant. 24/7 support for your success.